ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-EDA Antibody [DMC388] (Biotin) (A332262)

Recombinant chimeric monoclonal [DMC388] antibody to EDA (Biotin) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Anti-EDA Antibody [DMC388] (Biotin)
Description
Recombinant chimeric monoclonal [DMC388] antibody to EDA (Biotin).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Rabbit / Human
Clonality
Monoclonal
Clone ID
DMC388
Isotype
IgG1
Conjugate

Biotin

Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
This antibody is a recombinant rabbit chimeric monoclonal antibody containing human IgG1 Fc.
Synonyms
Ectodermal dysplasia protein, Ectodysplasin-A, ED1, EDA protein, EDA2
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-EDA Antibody [DMC388] (Biotin) (A332262)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with EDA

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.6% Relevancy Score
95.9% Relevancy Score
92.2% Relevancy Score
78% Relevancy Score
72.6% Relevancy Score
69.8% Relevancy Score
62.1% Relevancy Score
59.8% Relevancy Score